Omega Therapeutics Inc

NASDAQ:OMGA   4:00:00 PM EDT
6.70
0.00 (0.00%)
4:00:05 PM EDT: $6.70 0.00 (0.00%)
Other Pre-Announcement

Omega Therapeutics Reports Third Quarter Financial Results

Published: 11/08/2022 12:49 GMT
Omega Therapeutics Inc (OMGA) - Omega Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights.
Qtrly Net Loss per Common Stock Attributable to Common Stockholders, Basic and Diluted $0.54.
As of September 30, 2022, Company Had Cash, Cash Equivalents and Marketable Securities Totaling $148.3 Million.
Q3 Earnings per Share View $-0.62 -- Refinitiv Ibes Data (analyst estimates).